Presence & RecognitionEvent: September 7, 2026
Immunic Therapeutics is hosting its RMS R&D Day on September 9 featuring leading MS experts Dr. Amit Bar-Or and Dr. Stephen Krieger.
Published
Signal category
Presence & Recognition
Quote
“Immunic's RMS R&D Day on September 9, featuring leading multiple sclerosis (MS) experts Dr. Amit Bar-Or and Dr. Stephen Krieger and our manangement team”
— Immunic Therapeutics team
Company
Immunic Therapeutics
Immunic (Nasdaq: IMUX) is a late-stage biotechnology company developing novel oral therapies for neurologic diseases.
- Industry
- Biotechnology Research
- Location
- New York City, US
- Company size
- 99 employees
Immunic, Inc. (Nasdaq: IMUX) is a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases. Privacy Policy: https://imux.com/privacy-policy/
Founded 2016